Korro to Host Virtual Analyst Day on January 27, 2026

(NASDAQ:KRRO), – Program to feature presentations from the company management about KRRO-121 for the potential treatment of hyperammonemia, a leading clinical hepatologist about ammonia-driven diseases, and a caregiver sharing perspectives on living with urea cycle disorder – CAMBRIDGE, Mass., Jan. 20, 2026 (GLOBE NEWSWIRE) — Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that the […]

Xavier Creative House Unveils 2026 AI Strategy Focused on Responsible Automation, Measurable Growth, and Healthcare-Grade Compliance

Xavier Creative House (www.xaviercreativehouse.com), a woman-owned, independent healthcare marketing agency, today announced its 2026 Artificial Intelligence (AI) strategy, outlining a disciplined, production-ready approach to AI adoption designed to drive efficiency, scalability, and measurable commercial impact for life sciences organizations. As healthcare marketing teams face mounting pressure to do more with less while navigating increasingly complex

Signing Day Sports Provides Update on Business Combination with BlockchAIn

(NYSE MKT:SGN), Proposed Combined Company Will be a Cash-Generating, AI-Focused Digital Infrastructure Platform AI-Ready Data Centers, Low-Cost Power and Strategic U.S. Locations Anchor Long-Term Operating Strategy BlockchAIn 2024 Revenue of ~$22.9 Million and Net Income of ~$5.7 Million, with Infrastructure Expansion Expected to Support Up to 5x Increase in Data Center Capacity Over Time Business

Zapata Quantum CEO Sumit Kapur Addresses Global Leaders at Davos on the Next Phase of Quantum Applications

(PinkSheets:ZPTA),(Pinksheets:ZPTA), DAVOS, Switzerland, Jan. 20, 2026 (GLOBE NEWSWIRE) — Sumit Kapur, Chief Executive Officer of Zapata Quantum Inc. (OTC: ZPTA) (“Zapata”, “Zapata Quantum” or the “Company”), spoke today to global business and technology leaders in Davos, Switzerland. In his remarks on two separate panels, he outlined why the next phase of quantum computing will be

Expanded Insurance Coverage Validates Circle’s AI Approach to Coronary Plaque Evaluation

Highlights New permanent Category I CPT code 75577 for AI-enabled coronary plaque analysis took effect January 1, 2026 Major payers, including Aetna, alongside UnitedHealthcare, Cigna, Humana, and others, now cover AI-enabled coronary plaque analysis, extending access to tens of millions of commercially insured patients Circle's FDA-cleared, on-premise cvi42|Plaque solution integrates directly into CCTA workflows, giving

SPX Technologies Announces Acquisition of Thermolec

(NYSE:SPXC), CHARLOTTE, N.C., Jan. 20, 2026 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE:SPXC) (“SPX Technologies” or the “Company”) announced today that it has completed the acquisition of Thermolec Ltd. (“Thermolec”) for a total cash consideration of CA$ 195 million (approximately US$ 140 million). Founded in 1973, Thermolec is a Montreal-based manufacturer of custom electric duct

Seed Talent Unveils Top Trained Dispensaries of 2025, Raising the Bar for Cannabis Retail and Consumer Experience

CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) — Seed Talent, the leading workforce development platform for the cannabis industry, announces the Top Trained Dispensaries of 2025, recognizing retail locations across the U.S. and Canada that are redefining what a world-class cannabis shopping experience looks like — through education. As cannabis demand continues to grow throughout North

Lynq Launches RavenTalk at SHOT Show, Redefining Secure, Infrastructure-Free Communications

LAS VEGAS, Jan. 20, 2026 (GLOBE NEWSWIRE) — Lynq Networks, a leader in local team communications addressing one of the largest connectivity challenges facing enterprises and governments, today announced the launch of RavenTalk at SHOT Show 2026. Built on Lynq's Raven network stack, RavenTalk delivers secure, long-range, hands-free, decentralized voice and data communications, without base

Cogent Biosciences to Initiate New Drug Application (NDA) Submission for Bezuclastinib Under Real-Time Oncology Review (RTOR)

(NASDAQ:COGT), – PEAK trial first ever study to demonstrate statistical significance over an active comparator in GIST patients, with bezuclastinib plus sunitinib combination demonstrating mPFS of 16.5 months and ORR of 46% in patients who had received prior treatment with imatinib – Cogent is expected to initiate the RTOR process immediately; completion of the PEAK

SoundThinking Appoints Kirk Arthur as Senior Vice President of Global Sales and Manuel Nylen as Vice President of Sales for SafePointe

(NASDAQ:SSTI), Summary: SoundThinking, Inc. strengthens sales leadership with the appointments of Kirk Arthur as SVP of Global Sales and Manuel Nylen as VP of Sales for SafePointe(R), positioning the company for accelerated growth across public safety, security, and enterprise markets. FREMONT, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — SoundThinking, Inc. (Nasdaq: SSTI), a leading public

Scroll to Top